Pfizer CEO Albert Bourla on Monday said that the company might move overseas manufacturing to its existing plants in the ...

The CHMP gives a positive opinion to Eli Lilly's Jaypirca in patients with relapsed or refractory CLL in a post-BTK inhibitor setting.

(Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in ...

Eli Lilly and Company, UnitedHealth Group, AbbVie, Walmart, Johnson & Johnson, Natera, and Gilead Sciences are the seven Medical stocks to watch today, according to MarketBeat’s stock screener tool.

Per the terms of the deal, AbbVie will lead the development and commercialization of the obesity drug developed by Gubra.

More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...

People who land in the ER after using hallucinogens are more than twice as likely to die in a handful of years, a new study ...

President Mung Chiang joins industry leaders during SXSW to discuss the university's role in shaping the future of pharmaWest Lafayette, In ...

On the eve of President Trump's tariffs, Reuters reported Honda would move production of the popular Civic to Indiana. Honda declined to comment.

LEQEMBI (lecanemab) has significant market potential due to the high global prevalence of the condition and the demand for disease-modifying treatmen ...

Over 30 state attorneys general including in Indiana, Kentucky, and Ohio have urged the Federal Food and Drug Administration ...

As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...